This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Dec 22;375(25):2499.

doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal

Joseph J Shatzel^{1

2}, Molly M Daughety¹, Thomas G DeLoughery¹

Affiliations

PMID: 28002712
DOI: 10.1056/NEJMc1613270

Comment

Andexanet Alfa for Factor Xa Inhibitor Reversal

Joseph J Shatzel et al. N Engl J Med. 2016.

. 2016 Dec 22;375(25):2499.

doi: 10.1056/NEJMc1613270.

Authors

Joseph J Shatzel^{1

2}, Molly M Daughety¹, Thomas G DeLoughery¹

Affiliations

¹ Oregon Health and Science University, Portland, OR
² shatzel@ohsu.edu

PMID: 28002712
DOI: 10.1056/NEJMc1613270

No abstract available

PubMed Disclaimer

Comment in

Andexanet Alfa for Factor Xa Inhibitor Reversal.
Hunt BJ, Levi M. Hunt BJ, et al. N Engl J Med. 2016 Dec 22;375(25):2500. doi: 10.1056/NEJMc1613270. N Engl J Med. 2016. PMID: 28009496 No abstract available.

Comment on

Engineering Reversal - Finding an Antidote for Direct Oral Anticoagulants.
Hunt BJ, Levi M. Hunt BJ, et al. N Engl J Med. 2016 Sep 22;375(12):1185-6. doi: 10.1056/NEJMe1610510. N Engl J Med. 2016. PMID: 27653570 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations